Physician profile
Ryan Carrick
NPI 1063542280
$1,130.00
in general payments reported to CMS, 2019-2025
17 companies · $54.14 in 2025
The $54.14 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $200 · 2021: $277 · 2022: $13.32 · 2023: $34.16 · 2024: $290 · 2025: $54.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $330.86 | 2019-2025 | Fasenra |
| Pfizer INC. | $292.27 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $119.84 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $54.89 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.25 | 2019 | |
| Mallinckrodt Enterprises LLC | $42.88 | 2019 | |
| Glaxosmithkline, LLC. | $42.18 | 2024-2025 | Trelegy Ellipta, Arexvy |
| United Therapeutics Corporation | $34.16 | 2023 | Tyvaso |
| Zoll Medical Corporation | $33.07 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.88 | 2020 | |
| Advanced Respiratory, INC | $22.79 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.24 | 2020 | |
| Alexion Pharmaceuticals, INC. | $15.64 | 2019 | |
| Abbott Laboratories | $14.93 | 2019 | |
| Resmed Corp | $13.32 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $12.94 | 2020 | |
| Novartis Pharmaceuticals Corporation | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Carrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.